The AGA Research Foundation has announced Horizon Pharma’s support of research awards aimed to stimulate interest in gastroenterology/ hepatology research careers through competition and recognition:
• AGA-Horizon Pharma Fellow Abstract Prizes provide three awards of $1,000 each to fellows who have submitted abstracts chosen to be presented during Digestive Disease Week (DDW).
• AGA-Horizon Pharma Student Abstract Prizes provide eight travel awards of $500 each to high school, undergraduate, graduate, and medical students who have submitted abstracts chosen by the AGA to be presented during DDW. Medical residents up to and including postgraduate year three are also eligible for the award. The three best student abstracts submitted will receive a $1,000 prize.
Amanda E. Troy, MS
"We are extremely thankful to Horizon Pharma for continuing to support promising young researchers whose work could make a positive impact on the lives of patients," said Dr. Nicholas F. LaRusso, AGAF, chair of the AGA Research Foundation. "Our partnership with Horizon Pharma helps to foster new research developments in the field - every individual donation makes a difference."
This year’s fellow abstract prize recipients are:
Veroushka Ballester, M.D., University of Puerto Rico, San Juan
Luke J. Engelking, M.D., Ph.D., UT Southwestern Medical Center, Dallas, TX
Milli Gupta, M.D., FRCPC, Mayo Clinic, Rochester, MN.
This year’s student abstract prize recipients are:
Farhan Anwar, University of Arizona, Tucson
Alexandra Cee, M.Sc., University Hospital, Zurich, Switzerland
Aaron R. Chavis, University of Michigan, Ann Arbor
Rui Feng, M.D., University of Cincinnati, OH
Trilokesh D. Kidambi, Northwestern University, Chicago, IL
Lin Lin, University of California, Los Angeles
Kei Nakagawa, University of Pennsylvania, Wynnewood
Michael A. Schumacher, M.S., University of Cincinnati, OH
Derrick J. Stobaugh, Northshore University Health System, Evanston, IL
Amanda E. Troy, M.S., Pennsylvania State College of Medicine, Hershey
Niels B. Vande Casteele, M.Sc., Catholic University of Leuven, Belgium
"We remain committed to investing in the future of gastroenterology by funding these grants," said Timothy P. Walbert, chairman, president, and chief executive officer of Horizon Pharma. "We applaud this year’s group of outstanding award recipients and look forward to their promising contributions to advancing the field."
Trilokesh D. Kdiambi
Horizon Pharma Inc. is a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain, and inflammatory diseases. For more information, please visit www. horizonpharma.com.
The AGA Research Foundation is the cornerstone of AGA’s effort to expand digestive disease research funding. Since 1984, the AGA, through its foundations, has provided more than $40 million in research grants to more than 670 scientists.
The AGA Research Foundation serves as a bridge to the future of research in gastroenterology and hepatology by providing critical funding to advance the careers of young researchers between the end of training and the establishment of credentials that earn NIH grants.
To learn more about the AGA Research Foundation or make a contribution, visit www.gastro.org/aga-foundation.
